Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1952 1
1953 2
1956 2
1957 1
1962 1
1965 2
1966 1
1967 2
1971 1
1973 1
1975 1
1976 1
1977 2
1978 1
1979 4
1980 2
1981 1
1982 6
1983 8
1984 3
1985 2
1986 1
1987 6
1988 5
1989 2
1990 1
1991 6
1992 4
1993 2
1994 4
1995 2
1996 4
1997 4
1998 2
1999 3
2000 3
2001 4
2002 8
2003 6
2004 2
2005 6
2006 5
2007 4
2008 11
2009 11
2010 9
2011 13
2012 5
2013 11
2014 4
2015 20
2016 15
2017 10
2018 4
2019 17
2020 21
2021 22
2022 16
2023 19

Text availability

Article attribute

Article type

Publication date

Search Results

311 results

Results by year

Filters applied: . Clear all
Page 1
Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition.
Pasciuto E, Burton OT, Roca CP, Lagou V, Rajan WD, Theys T, Mancuso R, Tito RY, Kouser L, Callaerts-Vegh Z, de la Fuente AG, Prezzemolo T, Mascali LG, Brajic A, Whyte CE, Yshii L, Martinez-Muriana A, Naughton M, Young A, Moudra A, Lemaitre P, Poovathingal S, Raes J, De Strooper B, Fitzgerald DC, Dooley J, Liston A. Pasciuto E, et al. Among authors: de la fuente ag. Cell. 2020 Aug 6;182(3):625-640.e24. doi: 10.1016/j.cell.2020.06.026. Epub 2020 Jul 22. Cell. 2020. PMID: 32702313 Free PMC article.
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity.
Osuchowski MF, Winkler MS, Skirecki T, Cajander S, Shankar-Hari M, Lachmann G, Monneret G, Venet F, Bauer M, Brunkhorst FM, Weis S, Garcia-Salido A, Kox M, Cavaillon JM, Uhle F, Weigand MA, Flohé SB, Wiersinga WJ, Almansa R, de la Fuente A, Martin-Loeches I, Meisel C, Spinetti T, Schefold JC, Cilloniz C, Torres A, Giamarellos-Bourboulis EJ, Ferrer R, Girardis M, Cossarizza A, Netea MG, van der Poll T, Bermejo-Martín JF, Rubio I. Osuchowski MF, et al. Among authors: de la fuente a. Lancet Respir Med. 2021 Jun;9(6):622-642. doi: 10.1016/S2213-2600(21)00218-6. Epub 2021 May 6. Lancet Respir Med. 2021. PMID: 33965003 Free PMC article. Review.
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial.
Giné E, de la Cruz F, Jiménez Ubieto A, López Jimenez J, Martín García-Sancho A, Terol MJ, González Barca E, Casanova M, de la Fuente A, Marín-Niebla A, Muntañola A, González-López TJ, Aymerich M, Setoain X, Cortés-Romera M, Rotger A, Rodríguez S, Medina Herrera A, García Sanz R, Nadeu F, Beà S, Campo E, López-Guillermo A. Giné E, et al. Among authors: de la fuente a. J Clin Oncol. 2022 Apr 10;40(11):1196-1205. doi: 10.1200/JCO.21.02321. Epub 2022 Jan 14. J Clin Oncol. 2022. PMID: 35030036 Free PMC article. Clinical Trial.
Horizontal ridge augmentation with guided bone regeneration using particulate xenogenic bone substitutes with or without autogenous block grafts: A randomized controlled trial.
Mendoza-Azpur G, de la Fuente A, Chavez E, Valdivia E, Khouly I. Mendoza-Azpur G, et al. Among authors: de la fuente a. Clin Implant Dent Relat Res. 2019 Aug;21(4):521-530. doi: 10.1111/cid.12740. Epub 2019 Mar 18. Clin Implant Dent Relat Res. 2019. PMID: 30884111 Clinical Trial.
Location of Gastrointestinal Stromal Tumor (GIST) in the Stomach Predicts Tumor Mutation Profile and Drug Sensitivity.
Sharma AK, de la Torre J, IJzerman NS, Sutton TL, Zhao B, Khan TM, Banerjee S, Cui C, Nguyen V, Alkhuziem M, Snaebjornsson P, van Boven H, Bruining A, Tang CM, Yoon H, De la Fuente A, Kato S, Patel H, Heinrich MC, Corless CL, Horgan S, Burgoyne AM, Fanta P, Mesirov JP, Blakely AM, Davis JL, Mayo SC, van Houdt WJ, Steeghs N, Sicklick JK. Sharma AK, et al. Among authors: de la fuente a. Clin Cancer Res. 2021 Oct 1;27(19):5334-5342. doi: 10.1158/1078-0432.CCR-21-1221. Clin Cancer Res. 2021. PMID: 34326133 Free PMC article.
Novel therapeutic approaches to target neurodegeneration.
de la Fuente AG, Pelucchi S, Mertens J, Di Luca M, Mauceri D, Marcello E. de la Fuente AG, et al. Br J Pharmacol. 2023 Jul;180(13):1651-1673. doi: 10.1111/bph.16078. Epub 2023 Apr 26. Br J Pharmacol. 2023. PMID: 36965025 Review.
[Ectopia cordis].
Gámez JM, de la Fuente A, García F. Gámez JM, et al. Among authors: de la fuente a. An Pediatr (Barc). 2010 Mar;72(3):223. doi: 10.1016/j.anpedi.2009.10.025. Epub 2010 Feb 10. An Pediatr (Barc). 2010. PMID: 20149770 Free article. Spanish. No abstract available.
Autoantibodies and microglia: boon or bane?
Naughton M, de la Fuente AG. Naughton M, et al. Among authors: de la fuente ag. Brain. 2021 Sep 4;144(8):2231-2233. doi: 10.1093/brain/awab269. Brain. 2021. PMID: 34382068 No abstract available.
311 results